William M. Webb, M.D., Ph.D.
Assistant Professor, Psychiatry and Behavioral Sciences
Professional Background
I am a physician-scientist trained in Internal Medicine and Psychiatry. Prior to completing residency at the University of Kansas Medical Center, I completed a Ph.D. in Neuroscience at the University of Alabama at Birmingham, where I studied the role of epigenetics of learning and memory processes.
Clinically, I have developed expertise in treating complex psychiatric and medical comorbidities across inpatient, outpatient, and state hospital settings. I am especially passionate about psychotic disorders and the unique challenges that this patient population face. My residency training at the University of Kansas Medical Center included leadership roles as Chief Resident in both Psychiatry and Internal Medicine, where I led multidisciplinary teams and contributed to clinical education and curriculum development.
Education and Training
- MD, Medicine, University of Alabama School of Medicine, Birmingham, Alabama
- PhD, Neuroscience, University of Alabama at Birmingham, Birmingham, Alabama
- BS, Biology, Millsaps College, Jackson, Mississippi
- Residency, Internal Medicine & Psychiatry, University of Kansas Medical Center, Kansas City, Kansas
Licensure, Accreditations & Certifications
- Internal Medicine, American Board of Internal Medicine
- Medical License, Kansas State Board of Healing Arts
- Medical License, Missouri State Board of Registration for the Healing Arts
- Psychiatry, American Board of Psychiatry and Neurology
Research
Overview
My research background focuses on the molecular mechanisms underlying memory formation and neuropsychiatric disease, particularly the role of epigenetic regulation in neural plasticity. During my Ph.D. training, I investigated NF-κB signaling and histone methylation in memory processes. My recent scholarly work bridges translational neuroscience and clinical psychiatry, including studies on treatment-resistant depression, medication-induced psychiatric effects, and emerging therapeutic strategies. I am particularly interested in advancing clinical trials in neuropsychiatric disorders that integrate biologically informed treatments with patient-centered approaches.